Transaction DateRecipientSharesTypePriceValue
1st February 2021Dane Andreeff5,700Grant/award etc.$14.81$84,417.00
1st February 2021Dane Andreeff2,900Grant/award etc.$14.81$42,949.00
1st February 2021Dane Andreeff1,800Grant/award etc.$14.81$26,658.00
1st February 2021Dane Andreeff6,468Grant/award etc.$14.81$95,791.08
21st October 2020Dane Andreeff371,883Grant/award etc.$0.46$171,772.76
21st October 2020Joyce N La Viscount38,138Grant/award etc.$0.46$17,615.94
21st October 2020Dane Andreeff37,363Grant/award etc.$0.46$17,257.97
21st October 2020Dane Andreeff638,182Grant/award etc.$0.46$294,776.27
21st October 2020Dane Andreeff134,873Grant/award etc.$0.46$62,297.84
31st July 2020Joyce N La Viscount4,946Grant/award etc.$0.56$2,745.03
Helius Medical Technologies
Helius Medical Technologies logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.


Helius Medical Technologies, Inc. focuses on licensing and acquiring platform technologies that amplify the brain's ability to heal itself. The company was founded in 2014 and is headquartered in Newtown, PA.


Ticker: HSDT
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1610853
Employees: 19
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals